The role of microvascularization and growth/adhesion-regulatory lectins in the prognosis of non-small cell lung cancer in stage II

European Journal of Cardio-thoracic Surgery

Volumn 31, Issue 5, 2007, Pages 784-788

  Szöke, Tamas ^a   Kayser, Klaus ^b   Trojan, Imre ^a   Kayser, Gian ^c   Furak, Jozsef ^a   Tiszlavicz, Laszlo ^d   Baumhäkel, Jan Dirk ^b   Gabius, Hans Joachim ^e  

^a UNIVERSITY OF SZEGED   (Hungary)

^b HUMBOLDT UNIVERSITY   (Germany)

^c UNIVERSITY OF FREIBURG   (Germany)

^d UNIVERSITY OF SZEGED   (Hungary)

^e UNIVERSITY OF MUNICH   (Germany)

Author keywords

Lectins; Lung cancer; Microvascularization; Syntactic structure analysis

Indexed keywords

GALECTIN 1; GALECTIN 3; HEPARIN BINDING PROTEIN; HYALURONIC ACID; LECTIN; GALECTIN; TUMOR PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MALE; MICROVASCULARIZATION; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SURFACE PROPERTY; SURVIVAL; CANCER STAGING; CHEMISTRY; LUNG TUMOR; METHODOLOGY; MICROCIRCULATION; MIDDLE AGED; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); TREATMENT OUTCOME; VASCULARIZATION;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GALECTIN 1; GALECTIN 3; GALECTINS; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; MALE; MICROCIRCULATION; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; TREATMENT OUTCOME;

EID: 34047134551     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2007.01.072     Document Type: Article

References (23)

1. Gabius H.J. Concepts of tumour lectinology. Cancer Invest 15 (1997) 454-464
2. Gabius H.J. Animal lectins. Eur J Biochem 243 (1997) 543-576
3. Takenaka Y., Fukumori T., and Raz A. Galectin-3 and metastasis. Glycoconj J 19 (2004) 543-549
4. Grassadonia A., Tinari N., Iurisci I., Piccolo E., Cumashi A., Innominato P., D'Egidio M., Natoli C., Piantelli M., and Iacobelli S. 90K (Mac-2 BP) and galectins in tumour progression and metastasis. Glycoconj J 19 (2004) 551-556
5. Ochieng J., Furtak V., and Lukyanov P. Extracellular function of galectin-3. Glycoconj J 19 (2004) 527-535
6. Hsu D.K., and Liu F.T. Regulation of cellular homeostasis by galectins. Glycoconj J 19 (2004) 507-515
7. Moon B.K., Lee Y.J., Battle P., Jessup J.M., Raz A., and Kim H.R.C. Galectin-3 protects human breast carcinoma cells against nitric oxide-induced apoptosis. Am J Pathol 159 (2001) 1055-1060
8. André S., Kojima S., Yamazaki N., Fink C., Kaltner H., Kayser K., and Gabius H.J. Galectins-1 and -3 and their ligands in tumour biology. J Cancer Res Clin Oncol 125 (1999) 461-474
9. Macchiarini P., Fontanini G., Hardin M.J., Squartini F., and Angeletti C.A. Relation of neovascularisation to metastasis of non-small-lung cancer. Lancet 340 (1992) 145-146
10. Kayser K., Richter B., Stryciak R., and Gabius H.J. Parameters derived from integrated nuclear fluorescence, syntactic structure analysis, and vascularization in human lung carcinomas. Anal Cell Pathol 15 (1997) 73-83
11. Harpole D.H.J., Richards W.G., Herndon J.E., and Sugarbaker D.J. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lug cancer. Ann Thorac Surg 61 (1996) 1470-1476
12. Meert A., Paesmans M., Martin B., Delmotte P., Berghmans T., Verdebout J., Lafitte J., Mascaux C., and Sculier J. The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis. Br J Cancer 87 (2002) 694-701
13. Kayser G., Baumhäkel J.D., Szöke T., Trojan I., Riede U., Werner M., and Kayser K. Vascular diffusion density and survival of patients with primary lung carcinomas. Virchows Arch 442 (2003) 267-462
14. The International Adjuvant Lung Cancer Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small cell long cancer. N Engl J Med 350 (2004) 351-360
15. Kayser K, Gabius HJ. Graph theory and the entropy concept in histochemistry. Stuttgart: Gustav Fischer, 1997:54.
16. Ochieng J., Green B., Evans S., James O., and Warfield P. Modulation of the biological function of galectin-3 by matrix-6 metalloproteinases. Biochim Biophys Acta 1379 (1998) 97-106
17. Nangia Makker P., Honjo Y., Sarvis R., Akahani S., Hogan V., Pienta K.J., and Raz A. Galectin-3 induces endothelial cell morphogenesis an angiogenesis. Am J Pathol 156 (2000) 899-909
18. Szöke T., Kayser K., Baumhäkel J.D., Trojan I., Furak J., Tiszlavicz L., Horvath A., Szluha K., Gabius H.J., and Andre S. Prognostic significance of endogenous adhesion/growth-regulatory lectins in lung cancer. Oncology 69 (2005) 167-174
19. Honjo Y., Inohara H., Akahani S., Yoshii T., Takenaka Y., Yoshida J., Hattori K., Tomiyama Y., Raz A., and Kubo T. Expression of cytoplasmic galectin-3 as prognostic marker in tongue carcinoma. Clin Cancer Res 6 (2000) 4635-4640
20. Akahani S., Nangia-Makker P., Inohara H., Kim H.R., and Raz A. Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res 57 (1997) 5272-5276
21. Rorive S., Belot N., Decaestecker C., Lefarnc F., Gordower L., Micik S., Maurage C.A., Kaltner H., Ruchoux M.M., Danguy A., Gabius H.J., Salmon I., Kiss R., and Camby I. Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumour astocytes into the brain parenchyma. Glia 33 (2001) 241-255
22. Paz A., Haklai R., Elad-Sfadia G., Ballan E., and Kloog Y. Galectin-1 binds oncogenic H-Ras to mediate Ras membrae anchorage and cell transformation. Oncogene 20 (2001) 7486-7493
23. Fischer C., Gilbertson B.S., Powers E.A., Petzold G., Poorman R., and Michtchell M.A. Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 162 (1994) 499-510